Skip to main content

Box 61

 Container

Contains 33 Results:

Cancer: Senate Cancer Coalition - the March Research Task Force, 1998 September

 File — Box: 61, Folder: 1
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1998 September

Cancer: Tamoxifen - consent, 1992-1994

 File — Box: 61, Folder: 2
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1992-1994

Cancer: Tamoxifen - Food and Drug Administration (FDA) testimony, 1994

 File — Box: 61, Folder: 3
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1994

Cancer: Tamoxifen - prevention trial, 1994-1995

 File — Box: 61, Folder: 4
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1994-1995

Food and Drug Administration (FDA) Modernization Act: Access to experimental perscriptions, 1991

 File — Box: 61, Folder: 5
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1991

Food and Drug Administration (FDA) Modernization Act: Off-label bill - American Medical Association (AMA), 1997

 File — Box: 61, Folder: 6
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1997

Food and Drug Administration (FDA) Modernization Act: Off-label bill - conference, 1997

 File — Box: 61, Folder: 7
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1997

Food and Drug Administration (FDA) Modernization Act: Off-label bill - implimenting regulations, 1998

 File — Box: 61, Folder: 8
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1998

Food and Drug Administration (FDA) Modernization Act: Off-label bill - labor committee, 1996

 File — Box: 61, Folder: 9
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1996

Food and Drug Administration (FDA) Modernization Act: Off-label bill - language, 1995-1997

 File — Box: 61, Folder: 10
Scope and Contents From the Sub-Series:

Mark H. Smith worked as a legislative correspondent from 1989-1992 and then a legislative assistant from 1991-2000. He specialized in issues related to cancer, government affairs, health care, small business, social security, and appropriations. Prominent issues include the Cancer Screening Incentive Act, the Senate Cancer Coalition, and the Food and Drug Administration Modernization Act. This subseries is arranged alphabetically.

Dates: 1995-1997